New Drug Protein Targets
These drug targets relate to the particular protein in the body which is key to the drug's activity.
The drug binding to a particular protein may act to inhibit or activate said protein. However, in the case of protein replacement or gene therapies, or certain vaccines, the drug or its expression product will be the target. Many of these targets may have a Target Family assigned to them; this is a way of grouping together protein targets by their activity, such as enzyme types (including protein kinases), receptors, cytokines, ion channels, peptide hormones, or transporters.
-
July 2009 Drug Targets
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
tumor necrosis factor (ligand) superfamily, member 14
midkine (neurite growth-promoting factor 2)
CD300 molecule-like family member f
more -
June 2009 Drug Targets
cyclin E1
VP24, Zaire Ebola virus
nicotinamide phosphoribosyltransferase
apolipoprotein C-III
more -
May 2009 Drug Targets
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
mitogen-activated protein kinase-activated protein kinase 5
tyrosyl-DNA phosphodiesterase 1
lysophosphatidic acid receptor 1
more -
April 2009 Drug Targets
claudin 3
chemokine (C-X-C motif) ligand 16
CD200 receptor 1
tripartite motif-containing 37
more -
March 2009 Drug Targets
placenta-specific 1
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
SH3 domain containing ring finger 1
myelin associated glycoprotein
more -
February 2009 Drug Targets
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative)
guanine nucleotide binding protein (G protein), q polypeptide
pim-3 oncogene
toll-like receptor 5
more -
January 2009 Drug Targets
cholinergic receptor, nicotinic, alpha 6
more -
December 2008 Drug Targets
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
catenin (cadherin-associated protein), beta 1, 88kDa
F11 receptor
glypican 3
more -
November 2008 Drug Targets
solute carrier family 6 (neurotransmitter transporter, L-proline), member 7
microRNA 296
retinoic acid receptor responder (tazarotene induced) 3
CD27 molecule
more -
October 2008 Drug Targets
fibroblast growth factor receptor 4
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homologue
haemopoietic cell kinase
smoothened homologue (Drosophila)
more -
September 2008 Drug Targets
deoxycytidine kinase
C-type lectin domain family 9, member A
Bernardinelli-Seip congenital lipodystrophy 2 (seipin)
bone gamma-carboxyglutamate (gla) protein
more -
August 2008 Drug Targets
TIMP metallopeptidase inhibitor 3
integral membrane protein 2B
nucleoporin 85kDa
aquaporin 2 (collecting duct)
more -
July 2008 Drug Targets
microRNA 208a
ras homologue gene family, member C
glutaminyl-peptide cyclotransferase (glutaminyl cyclase)
Prominin 1
more -
June 2008 Drug Targets
amine oxidase (flavin containing) domain 2
keratin 6A
glutamate receptor, metabotropic 7
klotho beta
more -
May 2008 Drug Targets
polo-like kinase 3 (Drosophila)
more -
April 2008 Drug Targets
oncomodulin
prostaglandin D2 synthase, hematopoietic
pyruvate kinase, muscle
more -
March 2008 Drug Targets
activin A receptor type II-like 1
CD9 molecule
more -
January 2008 Drug Targets
indoleamine-pyrrole 2,3 dioxygenase
peptidylprolyl isomerase B (cyclophilin B)
more -
December 2007 Drug Targets
protease, serine, 12 (neurotrypsin, motopsin)
glutamate receptor, metabotropic 4
more -
November 2007 Drug Targets
myristoylated alanine-rich protein kinase C substrate
MAP kinase interacting serine/threonine kinase 1
more -
October 2007 Drug Targets
angiopoietin 1
inducible T-cell co-stimulator ligand
protein kinase D1
protein kinase C, iota
protein kinase N1
ADAMTS 13
more -
September 2007 Drug Targets
interleukin 25
angiopoietin-like 4
bone morphogenetic protein 4
potassium voltage-gated channel, shaker-related subfamily, member 2
transient receptor potential cation channel, subfamily V, member 3
more -
August 2007 Drug Targets
caspase 2
CD163 molecule
interleukin 17 receptor C
lectin, galactoside-binding, soluble, 9 (galectin 9)
secreted frizzled-related protein 1
more -
July 2007 Drug Targets
Endogenous retroviral family W, env (C7), member 1 (syncytin)
G protein-coupled bile acid receptor 1
integrin, alpha 9
SHC (Src homology 2 domain containing) transforming protein 1
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10
voltage-dependent anion channels 2 and 3
more -
June 2007 Drug Targets
circumsporozoite protein, Plasmodium yoelii
D-amino-acid oxidase
epoxide hydrolase 2, cytoplasmi
FK506 binding protein 8, 38kDa
hepatocyte erythrocyte protein 17 kDa, Plasmodium yoelii
peripherin 2 (retinal degeneration, slow)
potassium inwardly-rectifying channel, subfamily J, member 2
SLAM family member 6
v-raf murine sarcoma 3611 viral oncogene homologue
more -
May 2007 Drug Targets
3-phosphoinositide dependent protein kinase-1
CUB domain-containing protein 1
endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 4
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
Plexin domain-containing 1
solute carrier family 2, (facilitated glucose transporter) member 8
ubiquitin-activating enzyme E1C (UBA3 homologue, yeast)
more -
April 2007 Drug Targets
coagulation factor V (proaccelerin, labile factor)
cysteinyl leucotriene receptor 2
EPH receptor A1
exportin 1 (CRM1 homologue, yeast)
glycerol-3-phosphate acyltransferase, mitochondrial
low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor)
v-akt murine thymoma viral oncogene homologue 3 (protein kinase B, gamma)
G protein-coupled receptor 109A
high mobility group AT-hook 1
inducible T-cell co-stimulator
more -
March 2007 Drug Targets
CD83 molecule
CD47 molecule
complement component C3
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3
germ cell associated 2 (haspin)
histone deacetylase 6
interleukin 1, alpha
melanoma antigen family A, 4
NOL1/NOP2/Sun domain family, member 2
transient receptor potential cation channel, subfamily V, member 4
tumour-associated calcium signal transducer 2
more -
February 2007 Drug Targets
cadherin 3, type 1, P-cadherin (placental)
Delta-like 4 (DLL4)
guanylate binding protein 1, interferon-inducible, 67kDa
more -
January 2007 Drug Targets
5-hydroxytryptamine (serotonin) receptor 5A (5- HT5A)
Acid phosphatase, prostate (PAP)
aldehyde dehydrogenase 2 family (mitochondrial)
Aurora kinase C
AXL receptor tyrosine kinase
dihydropyrimidinase-like 2 (CRMP-2)
hemochromatosis type 2 (juvenile) (HJV)
lectin, galactoside-binding, soluble, 1 (galectin-1)
leucine-rich repeat kinase 2
Low density lipoprotein-related protein 2 (megalin)
Pim-1 oncogene
Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC1A)
Preferentially expressed antigen in melanoma (PRAME)
Prokineticin receptor 1 and prokineticin 1
PTK7 protein tyrosine kinase 7
Superoxide dismutase 2, mitochondrial
Torsin family 1, member A (torsin A)
Tumour suppressor candidate 4
V-set domain containing T-cell activation inhibitor 1
Zona pellucida glycoprotein 3 (sperm receptor)(ZP3)
more -
December 2006 Drug Targets
Myo-inositol oxygenase
Protein kinase N3
Prostaglandin D2 synthase 21kDa (brain)
Angiopoietin-2
YME1L1 YME1-like 1 (S. cerevisiae)
Low density lipoprotein receptor-related protein
more -
November 2006 Drug Targets
Transportin 1 and karyopherin (importin) beta 1
more -
October 2006 Drug Targets
mannosidase, alpha, class 2B, member 1
arylsulfatase A (ARSA)
hepatitis A virus cellular receptor 1
calcium channel, voltage-dependent, alpha 1F subunit
collagen, type IV, alpha 3 (Goodpastures antigen) binding protein
more
